DIANA RODRIGUEZ ORTIZ: Open Payments
NPI 1942076831 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,643 in 80 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $796 · 2025 $1,643
Food & beverage: $1,643
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $364 |
| Amgen Inc. | 13 | $279 |
| Madrigal Pharmaceuticals | 7 | $185 |
| Otsuka America Pharmaceutical, Inc. | 4 | $114 |
| Astellas Pharma US Inc | 5 | $104 |
| Novo Nordisk Inc | 6 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| ABBVIE INC. | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
Products named: REZDIFFRA, REPATHA, REXULTI, Veozah, AIRSUPRA, BREZTRI, Wegovy, Kerendia.
Industry payments across CO — which companies pay providers there.
